Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd.

Equities

300018

CNE100000GP0

Electrical Components & Equipment

End-of-day quote Shenzhen S.E. 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
4.89 CNY -2.78% Intraday chart for Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. +0.62% -19.97%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Wuhan Zhongyuan Huadian Chairman Resigns; Vice Chairman Succeeds MT
Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. cancelled the transaction announced on April 26, 2020 CI
Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Implements Cash Dividend for the Year 2022, Payable on 30 June 2023 CI
Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Approves Cash Dividend for the Year 2022 CI
Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Proposes Final Cash Dividend for the Year 2022 CI
Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Biaodi Electronics announced that it has received $1.5 million in funding from Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. CI
Rui Shuangyin agreed to acquire 35.56% stake in Anhui Daqian Bio-Engineering Limited Company from Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. for CNY 12.2 million. CI
Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021 CI
Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020 CI
Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Approves Election Directors CI
Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020 CI
Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020 CI
Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2019 CI
Chart Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd.
More charts
WUHAN ZHONGYUAN HUADIAN SCIENCE & TECHNOLOGY CO., LTD. is a China-based company principally engaged in the research, development, manufacture and sales of electrical power system intelligent record analysis products, time synchronization products, transformer substation integrated automation systems and automated distribution equipment, as well as the provision of related services for its products. The Company operates through two main segments. The Transmission and Distribution and Control Equipment Manufacturing segment is mainly engaged in the research, development, manufacture and sales of power failure recording devices, time synchronization devices, substation integrated automation system and distribution automation equipment. The Medical Health segment is engaged in the research, development and manufacture of medical information products and in-vitro diagnostic equipment.
Calendar
More about the company

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 300018 Stock
  4. News Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd.
  5. Wuhan Zhongyuan Huadian Chairman Resigns; Vice Chairman Succeeds